Atossa Genetics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (49)

View All

Latest Posts

About This Stock More About This Stock
MicroMarvel - Atossa Therapeutics
Article By: Jim Van Meerten
Saturday, April 6, 2024 7:49 PM EDT
Atossa Therapeutics, a biopharmaceutical company focused on developing medicines in oncology, has a lead program in Phase II clinical trials for breast cancer, and 100% technical buy signals
In this article: ATOS
Read
Penny Stocks To Buy Now According To Wall Street Analysts
Article By: Small Cap Reporter
Monday, May 17, 2021 10:00 AM EDT
Are analysts right about stocks in the market today?
In this article: ATOS, ARPO, PHUN Also: IWM, IJR
Read
Atossa Genetics Announces Pricing Of $5.1 Million Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, October 26, 2017 1:04 PM EDT
Atossa Genetics Inc. announced today the pricing of an underwritten public offering of 11,500,000 shares of common stock with a public offering price of $0.44 per share.
In this article: ATOS
Read
Healthcare Review: ELMD, EGLT, ECTE, ATOS, CBMX
Article By: BioMedReports
Thursday, September 25, 2014 3:16 AM EDT
The Dow Jones Industrial Average gained 102 points, or 0.6%, to 17158. The S&P 500 index added 10 points, or 0.5%, to 1993 and the Nasdaq Composite rose 34 points, or 0.8%, to 4543.
In this article: ECTE, CBMX, ELMD, EGLT, ATOS
Read
All Posts

Latest Tweets for $ATOS

No tweets yet!

PARTNER HEADLINES